Stock Report

Vivanza Biosciences Ltd Q4 FY24 consolidated loss at Rs. 41.40 lakhs



Posted On : 2024-05-02 11:05:43( TIMEZONE : IST )

Vivanza Biosciences Ltd Q4 FY24 consolidated loss at Rs. 41.40 lakhs

has reported Consolidated financial results for the period ended March 31, 2024.

Financial Results (Q4 FY2024) - QoQ Comparison

The company has reported total income of Rs. 4.3933 crores during the period ended March 31, 2024 as compared to Rs. 6.5793 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs. -0.4140 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 0.2060 crores for the period ended December 31, 2023.

The company has reported EPS of Rs. -0.10 for the period ended March 31, 2024 as compared to Rs. 0.05 for the period ended December 31, 2023.

Financials Q4 FY2024 Q3 FY2024 % Change
Total Income ₹ 4.3933 crs ₹6.5793 crs Up Tick / Down Tick-33.23%
Net Profit ₹-0.4140 crs ₹0.2060 crs Up Tick / Down Tick-300.97%
EPS ₹-0.10 ₹0.05 Up Tick / Down Tick-300.00%

Financial Results (Q4 FY2024) - YoY Comparison

The company has reported total income of Rs. 4.3933 crores during the period ended March 31, 2024 as compared to Rs.8.3627 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs.-0.4140 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.-0.1036 crores for the period ended March 31, 2023.

The company has reported EPS of Rs.-0.10 for the period ended March 31, 2024 as compared to Rs.-0.26 for the period ended March 31, 2023.

Financials Q4 FY2024 Q4 FY2023 % Change
Total Income ₹ 4.3933 crs ₹8.3627 crs Up Tick / Down Tick-47.47%
Net Profit ₹-0.4140 crs ₹-0.1036 crs Up Tick / Down Tick299.61%
EPS ₹-0.10 ₹-0.26 Up Tick / Down Tick61.54%

Financial Results (Year Ended FY2024) - YoY Comparison

The company has reported total income of Rs.27.8891 crores during the Financial Year ended March 31, 2024 as compared to Rs.18.2824 crores during the Financial Year ended March 31, 2023.

The company has posted net profit / (loss) of Rs.0.5473 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.0.5983 crores for the Financial Year ended March 31, 2023.

The company has reported EPS of Rs.0.14 for the Financial Year ended March 31, 2024 as compared to Rs.1.50 for the Financial Year ended March 31, 2023.

Financials Year Ended FY2024 Year Ended FY2023 % Change
Total Income ₹27.8891 crs ₹18.2824 crs Up Tick / Down Tick52.55%
Net Profit ₹0.5473 crs ₹0.5983 crs Up Tick / Down Tick-8.52%
EPS ₹0.14 ₹1.50 Up Tick / Down Tick-90.67%

Source : Equity Bulls

Keywords

VivanzaBiosciences Q4FY24 FY2024 ResultUpdate